Radico Khaitan
- Market Cap
- ₹62,503 Cr
- P/E
- 78.47
Key Fundamentals
MidcapBeveragesFMCGPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 24.20%
- Debt to Equity
- 0.11
- EPS (TTM)
- ₹59.45
- Book Value
- ₹273.92
- Market Cap
- ₹62,503 Cr
- P/E (TTM)
- 78.47
- P/B
- 17.03
- ROE
- 20.30%
- Dividend Yield
- 0.19%
- EBITDA
- ₹1,033 Cr
- 52W High
- ₹4,747.00
- 52W Low
- ₹2,500.00
- Day Range
- ₹4,594.60 – ₹4,666.20
- Volume
- 2,08,747
Peer Comparison
Fast Moving Consumer Goods › Beverages › Breweries & Distilleries
| 1,466.40 | 57.71 | 1,06,659 | 11.77 | 1.18% | 21.40% | 26.40% | 12,717 | 1,848 | |
| 4,665.00 | 78.47 | 62,503 | 17.03 | 0.19% | 20.30% | 24.20% | 6,480 | 796 | |
| 1,244.50 | 67.93 | 32,905 | 7.22 | 0.82% | 8.42% | 10.70% | 9,927 | 484 | |
| 794.30 | 97.34 | 22,217 | 13.53 | 0.68% | 14.30% | 18.40% | 4,137 | 216 | |
| 542.75 | — | 13,455 | 4.46 | 0.19% | 12.60% | 11.40% | 3,653 | −66 | |
| 796.07 | 22.88 | 5,336 | 4.01 | 0.00% | 20.20% | — | 9,071 | 233 | |
| 537.85 | 38.67 | 5,302 | 5.64 | 0.19% | 17.40% | 18.00% | 1,107 | 137 | |
| Median 7 companies | 796.07 | 62.82 | 22,217 | 7.22 | 0.19% | 17.40% | 18.20% | 6,480 | 233 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 75
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 23
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 63
- Good
- Sales & profit trajectory 9% weight
- Financial Health
- 88
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 91
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 48
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company has reduced debt.
Weaknesses
1- Stock is trading at 17.0 times its book value
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 4 | 3 | 12 |
| Oscillators | Bearish | 4 | 3 | 2 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Bearish
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 60.50
- Neutral
- MACD (12,26,9)
- 80.45
- Bullish
- SMA (50)
- 4,434.47
- Bullish
- SMA (200)
- 3,758.82
- Bullish
As of
Analyst Rating
17 of 20 analysts rate Buy, 2 Hold, 1 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +13.90% |
|---|---|
| 5Y | +20.52% |
| 3Y | +24.44% |
| 1Y | +24.65% |
| TTM | +15.77% |
Net profit
| 10Y | +22.71% |
|---|---|
| 5Y | +16.87% |
| 3Y | +40.02% |
| 1Y | +74.57% |
| TTM | +73.80% |
Operating cash flow
| 10Y | Turned positive |
|---|---|
| 5Y | +14.96% |
| 3Y | +45.95% |
| 1Y | +104.68% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +5.30 pp |
|---|---|
| 5Y | −0.30 pp |
| 3Y | +5.47 pp |
| 1Y | +3.01 pp |
| TTM | +4.56 pp |
Revenue by year
| Mar 2017 | ₹1,657 Cr |
|---|---|
| Mar 2018 | ₹1,797 Cr |
| Mar 2019 | ₹2,063 Cr |
| Mar 2020 | ₹2,395 Cr |
| Mar 2021 | ₹2,374 Cr |
| Mar 2022 | ₹2,859 Cr |
| Mar 2023 | ₹3,133 Cr |
| Mar 2024 | ₹4,106 Cr |
| Mar 2025 | ₹4,843 Cr |
| Mar 2026 | ₹6,037 Cr |
Net profit by year
| Mar 2017 | ₹80.00 Cr |
|---|---|
| Mar 2018 | ₹124 Cr |
| Mar 2019 | ₹194 Cr |
| Mar 2020 | ₹229 Cr |
| Mar 2021 | ₹277 Cr |
| Mar 2022 | ₹263 Cr |
| Mar 2023 | ₹220 Cr |
| Mar 2024 | ₹262 Cr |
| Mar 2025 | ₹346 Cr |
| Mar 2026 | ₹604 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Radico Khaitan Ltd trades at ₹4,605 as of 2026-11-13 with a market cap of ₹61,699 Cr. The company has delivered strong profit growth of 74% TTM and maintains a low debt-to-equity ratio of 0.15, but the stock commands a premium valuation at a P/E of 77.46x and a P/B of 16.81x.
- Exceptional TTM profit growth of 74%, significantly accelerating from the 5-year compounded profit growth of 17%, indicating a sharp improvement in earnings trajectory
- Very low debt-to-equity ratio of 0.15, and the company has been actively reducing debt, strengthening the balance sheet and lowering financial risk
- Robust 10-year compounded sales growth of 14% and a 3-year compounded sales growth of 24%, reflecting consistent top-line expansion over multiple cycles
- ROCE of 24% indicates efficient deployment of capital, suggesting the business generates healthy returns on total capital employed
- ROE improved to 20% in the last year from a 10-year average of 14%, pointing to an improving return profile for shareholders
- Stock has delivered a 1-year CAGR of 41% and a 10-year CAGR of 44%, demonstrating sustained long-term wealth creation
- 5-year compounded sales growth of 21% shows the company has maintained double-digit revenue expansion over a meaningful period
- 3-year compounded profit growth of 41% is nearly double the 3-year sales growth of 24%, suggesting meaningful margin expansion in recent years
- P/E ratio of 77.46x is significantly elevated relative to typical FMCG peers, leaving limited room for earnings disappointment
- Stock trades at 16.81x book value, a steep premium that prices in substantial future growth and raises risk of a de-rating if growth slows
- Dividend yield of just 0.2% offers negligible income return, meaning investor returns depend almost entirely on capital appreciation
- TTM profit growth of 74% is far above the 10-year compounded profit growth of 23%, raising questions about whether this pace is sustainable or driven by one-off factors
- ROE of 18.23% on a trailing basis, while respectable, may not fully justify a P/B multiple of 16.81x without continued earnings acceleration
- The stock has rallied 84% from its 52-week low of ₹2,500, which may embed optimistic expectations that are vulnerable to correction on any operational miss
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Radico Khaitan is executing a textbook premiumisation playbook — H1FY27 profit surged 67.8%, premium volumes grew 35.8%, and the balance sheet is approaching net-debt-free status. Vodka leadership (~60% market share) is the key margin driver, with 2-3x the unit profitability of whisky. Key risks are grain and packaging cost inflation, declining regular volumes, and concentration in the still-small vodka category (6.3% of industry). With Q3 tracking ahead of guidance and P&A growth guidance upgraded to 30%, the earnings trajectory remains firmly upward if input costs stabilise in H2.
- Packaging and grain cost inflation Nov 19
Packaging and grain costs remain inflationary. Firmer margin guidance is deferred until raw material prices stabilise, with potential relief from new crop arrivals and FCI releases in H2.
- DRI seizes ₹2.64 crore goods Nov 10
The Directorate of Revenue Intelligence seized goods worth ₹2.64 crore from Radico Khaitan over a customs tariff dispute. The company states operations remain unaffected.
- Regular volumes declining 12.5% Nov 02
Regular & Others category volumes fell 12.5% in H1FY27 and 9.7% in Q2 alone, driven by a high base, route-to-market changes in Andhra Pradesh, and policy shifts in Maharashtra and Karnataka.
- H1FY27 profit surges 67.8% Nov 02
Net profit jumped 67.8% to ₹457 crore in H1FY27. EBITDA rose 50.9% to ₹705 crore with margins expanding to 20.5% from 15.6%, and gross margins widened 530 bps to 48.6%.
- Q2 profit jumps 66.5% YoY Oct 27
Q2FY27 consolidated net profit rose 66.5% to ₹232.34 crore. EBITDA surged 50.6% to ₹357 crore with margins expanding to 6.39% from 4.69%. The company achieved highest-ever quarterly volumes, revenue, and profitability.
- Premium volumes up 35.8% Oct 27
Prestige & Above volumes grew 35.8% to 10.5 million cases in H1FY27, now accounting for 53.4% of own volumes vs 42.5% a year ago. FY27 P&A volume growth guidance upgraded to 30%.
- Investor meetings scheduled Nov 2026 Nov 10
Senior management scheduled investor engagements at conferences in Singapore and India from November 16-18, 2026, and a one-on-one with Premji Investments on November 3.
- CFO elevated to Board Oct 27
Dilip Kumar Banthiya was elevated to Executive Director and CFO effective October 28, 2026. Saket Somani was named Deputy CFO to strengthen the finance leadership team.
- Valuation below 5-year median P/E Nov 02
Radico trades at a trailing P/E of 68.4, below its 5-year median of 82.2, suggesting the current valuation is better supported by its recent earnings acceleration than peers.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 925 | 1,161 | 1,079 | 1,137 | 1,116 | 1,294 | 1,304 | 1,506 | 1,494 | 1,547 | 1,504 | 1,685 | 1,745 |
| Expenses | 804 | 1,018 | 959 | 990 | 955 | 1,111 | 1,127 | 1,274 | 1,256 | 1,280 | 1,219 | 1,336 | 1,388 |
| Operating Profit | 121 | 143 | 120 | 147 | 162 | 183 | 178 | 232 | 238 | 267 | 284 | 349 | 357 |
| OPM % | 13% | 12% | 11% | 13% | 14% | 14% | 14% | 15% | 16% | 17% | 19% | 21% | 20% |
| Other Income | 4 | 4.83 | 2 | 3.68 | 1 | 1 | 1.38 | −5 | 2.37 | −7 | 10 | 9 | 5.05 |
| Interest | 12 | 18 | 17 | 18.45 | 17 | 20 | 22 | 16 | 16 | 16 | 15 | 12 | 11 |
| Depreciation | 26 | 32 | 32 | 33 | 36 | 36 | 36 | 36 | 37 | 37 | 42 | 41 | 43 |
| PBT | 86 | 98.13 | 74 | 100 | 110 | 130 | 121 | 174 | 186 | 206 | 237 | 305 | 308 |
| Tax % | 25% | 24% | 27% | 25% | 27% | 26% | 25% | 25% | 25% | 25% | 24% | 25% | 25% |
| Net Profit | 65 | 75 | 54 | 75 | 81 | 95 | 92 | 131 | 140 | 155 | 179 | 230 | 232 |
| EPS (₹) | 4.85 | 5.62 | 4.03 | 5.64 | 6.03 | 7.14 | 6.88 | 9.75 | 10.42 | 11.57 | 13.40 | 17.14 | 17.34 |
| YoY Sales growth | 21 | 47 | 30 | 19 | 21 | 11 | 21 | 33 | 34 | 20 | 15 | 12 | 17 |
Profit & Loss
₹ Cr| Particulars | Mar 2007 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 580 | 1,643 | 1,657 | 1,797 | 2,063 | 2,395 | 2,374 | 2,859 | 3,133 | 4,106 | 4,843 | 6,037 | 6,480 |
| Expenses | 499 | 1,452 | 1,444 | 1,526 | 1,713 | 2,023 | 1,965 | 2,457 | 2,775 | 3,599 | 4,169 | 5,015 | 5,222 |
| Operating Profit | 81 | 191 | 214 | 270 | 351 | 372 | 409 | 402 | 359 | 507 | 674 | 1,022 | 1,258 |
| OPM % | 14% | 12% | 13% | 15% | 17% | 16% | 17% | 14% | 11% | 12% | 14% | 17% | 19% |
| Other Income | 30 | 41 | 18 | 27 | 13 | 9.19 | 20.07 | 7 | 25 | 15 | 5 | 1 | 19 |
| Interest | 39 | 85 | 81 | 69 | 36 | 32 | 22 | 13 | 22 | 59.15 | 74 | 64.03 | 55 |
| Depreciation | 16 | 43 | 42 | 41 | 42 | 53 | 54 | 65 | 71 | 114 | 140 | 153 | 164 |
| Exceptional Items | — | — | — | — | — | −24.17 | — | — | — | — | — | — | — |
| PBT | 57 | 103 | 109 | 188 | 286 | 273 | 353 | 332 | 291 | 348 | 465 | 805 | 1,058 |
| Tax % | 20% | 24% | 26% | 34% | 34% | 17% | 24% | 25% | 24% | 25% | 26% | 25% | — |
| Net Profit | 45 | 78 | 80 | 124 | 194 | 229 | 277 | 263 | 220 | 262 | 346 | 604 | 796 |
| EPS (₹) | 4.69 | 5.87 | 6.03 | 9.30 | 14.55 | 17.16 | 20.75 | 19.69 | 16.48 | 19.61 | 25.83 | 45.14 | 59.45 |
| Div. Payout % | 11% | 14% | 13% | 11% | 8% | 12% | 12% | 15% | 18% | 15% | 15% | 20% | — |
| Sales growth | 25 | — | 1 | 8 | 15 | 16 | −1 | 20 | 10 | 31 | 18 | 25 | 16 |
Balance Sheet
₹ Cr| Particulars | Mar 2007 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 19 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 166 | 951 | 1,018 | 1,130 | 1,309 | 1,516 | 1,766 | 2,000 | 2,181 | 2,413 | 2,727 | 3,289 | 3,643 |
| Borrowings | 690 | 960 | 799 | 592 | 337 | 400 | 288 | 202 | 754 | 818 | 750 | 498 | 394 |
| Other Liabilities | 133 | 390 | 392 | 498 | 581 | 540 | 543 | 555 | 762 | 846 | 1,163 | 1,181 | 1,431 |
| Total Liabilities | 1,007 | 2,327 | 2,235 | 2,247 | 2,253 | 2,483 | 2,624 | 2,784 | 3,724 | 4,104 | 4,668 | 4,995 | 5,496 |
| Fixed Assets | 285 | 729 | 704 | 685 | 714 | 743 | 810 | 821 | 1,234 | 1,700 | 1,811 | 1,910 | 1,906 |
| CWIP | 44 | 2 | 2 | 20 | 16 | 18 | 38 | 30 | 327 | 54 | 23 | 76 | 174 |
| Investments | 10 | 220 | 220 | 220 | 176 | 178 | 184 | 175 | 191 | 198 | 198 | 240 | 245 |
| Other Assets | 668 | 1,376 | 1,309 | 1,321 | 1,347 | 1,543 | 1,592 | 1,757 | 1,971 | 2,152 | 2,635 | 2,769 | 3,170 |
| Total Assets | 1,007 | 2,327 | 2,235 | 2,247 | 2,253 | 2,483 | 2,624 | 2,784 | 3,724 | 4,104 | 4,668 | 4,995 | 5,496 |
Cash Flow
₹ Cr| Particulars | Mar 2007 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | — | −36 | 250 | 316 | 309 | 60 | 370 | 222 | 239 | 166 | 363 | 743 |
| Investing | — | 81 | 5 | −21 | −7 | −67 | −76 | −108 | −705 | −226 | −171 | −266 |
| Financing | — | −87 | −234 | −293 | −226 | 9 | −183 | −134 | 487 | 24 | −237 | −446 |
| Net Cash Flow | — | −42 | 21 | 2 | 76 | 2 | 111 | −20 | 21 | −36 | −46 | 30 |
| Free Cash Flow | — | −4 | 232 | 272 | 237 | −20 | 241 | 86 | −466 | −60 | 189 | 504 |
| CFO/EBITDA | — | −8 | 124 | 130 | 110 | 39 | 109 | 78 | 87 | 47 | 67 | 90 |
Ratios
| Particulars | Mar 2007 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 96 | 136 | 137 | 128 | 114 | 125 | 107 | 96 | 96 | 87 | 89 | 72 |
| Inventory Days | 155 | 113 | 199 | 231 | 270 | 209 | 283 | 234 | 292 | 211 | 246 | 221 |
| Days Payable | 160 | 72 | 0 | 159 | 183 | 148 | 151 | 102 | 112 | 123 | 148 | 117 |
| Cash Conversion Cycle | 91 | 176 | 336 | 201 | 201 | 187 | 239 | 228 | 277 | 175 | 187 | 177 |
| Working Capital Days | 221 | 36 | 20 | 44 | 76 | 85 | 104 | 109 | 75 | 67 | 72 | 71 |
| ROCE % | 14% | — | 10% | 14% | 19% | 18% | 18% | 16% | 12% | 13% | 16% | 24% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Radico Khaitan insights
72 extracted metrics across FY07–FY27.
Documents
- Q2 FY27 concall · Nov 2026Transcript PPT Recording
- Q2 FY27 concall · Oct 2026PPT
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Q1 FY27 concall · Jul 2026PPT
- Q4 FY26 concall · May 2026Transcript PPT Recording
- 9 Jul 2026
- 9 Jul 2025
- 18 Jun 2024
- 29 Aug 2023
- 20 Jun 2023
- General announcements 11 Nov 2026
- General announcements 10 Nov 2026
Frequently Asked Questions about Radico Khaitan
What does Radico Khaitan Ltd do?
Where is Radico Khaitan Ltd (RADICO) listed?
Which sector does Radico Khaitan Ltd belong to?
What is the market capitalisation of Radico Khaitan Ltd?
What is the PE ratio of Radico Khaitan Ltd?
What is the 52-week high and low of Radico Khaitan Ltd?
Does Radico Khaitan Ltd pay dividends?
What is the Return on Equity (ROE) of Radico Khaitan Ltd?
Company Information
Incorporated in the year 1943, Radico Khaitan is one of the most recognised IMFL (Indian Made Foreign Liquor) brands in India. The company was initially known as Rampur Distillery Company and was focussed on distillation and bottling for branded players and canteen stores of armed forces. Later on in the year 1997, Radico Khaitan ventured into its own branded IMFL products and launched its first brand 8PM whisky which became its millionarie brand within a year of its launch.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/RADICO.md for Radico Khaitan Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.